Kyle W. Gano
2016
In 2016, Kyle W. Gano earned a total compensation of $2.3M as Chief Business Development Officer at Neurocrine Biosciences.
Compensation breakdown
Bonus | $155,250 |
---|---|
Option Awards | $734,916 |
Salary | $345,000 |
Stock Awards | $1,014,918 |
Other | $4,363 |
Total | $2,254,447 |
Gano received $1M in stock awards, accounting for 45% of the total pay in 2016.
Gano also received $155.3K in bonus, $734.9K in option awards, $345K in salary and $4.4K in other compensation.
Rankings
In 2016, Kyle W. Gano's compensation ranked 4,358th out of 14,075 executives tracked by ExecPay. In other words, Gano earned more than 69.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,358 out of 14,075 | 69th |
Division Manufacturing | 1,532 out of 5,489 | 72nd |
Major group Chemicals And Allied Products | 462 out of 1,895 | 76th |
Industry group Drugs | 335 out of 1,538 | 78th |
Industry Biological Products, Except Diagnostic Substances | 63 out of 279 | 77th |
Source: SEC filing on April 17, 2019.
Gano's colleagues
We found five more compensation records of executives who worked with Kyle W. Gano at Neurocrine Biosciences in 2016.
2016
Kevin Gorman
Neurocrine Biosciences
Chief Executive Officer
2016
Timothy Coughlin
Neurocrine Biosciences
Chief Financial Officer
2016
Christopher O'Brien
Neurocrine Biosciences
Chief Medical Officer
2016
Haig Bozigian
Neurocrine Biosciences
Chief Development Officer
2016
Eric Benevich
Neurocrine Biosciences